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Patients with increased ExBP showed significantly higher (~~0.05 - 0.001) Idl-cholesterol 
and triglyceride levels and significantly lower hdl-cholesterol levels. 
Conclusions: Despite normotensive BP during ABPM. obese patients frequently show a 
pathologically increased BP response during standardized ergometry. This increased BP 
response to exercise has an influence not only on LVMI, but also on cardiovascular mor- 
tality, and should therefore be assessed in obese patients. 
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1032-120 Expression of NAD(P)H Oxidase Components in Human 
Platelets 
Naglaa A. ECSherbeeny, Lawrence T. McGrath. Lana J. Dixon, Siobhan Brennan, @y 
E. McVeiah Queen’s University Belfast, Belfast, United Kingdom 
Background. Nitric oxide (NO) is involved in vasodilation. This is related to the bioavail- 
ability of NO, rather than absolute production. A major scavenger of NO is the superoxide 
anion which is released by endothelial and vascular smooth muscle cells. Platelets 
release both NO and superoxide and share many pathways found in endothelial cells. 
We examined human platelets for components of of the superoxide generating system, 
NAD(P)H oxidase. Methods. Platelets and leukocytes were prepared by sequential cen- 
trifugation and lysed in buffer containing n-octyl-D-glucopyranoside (ODG). Early pas- 
sage human aortic endothelial cells (HAECs) were cultured until confluence, washed and 
lysed in ODG containing buffer. Standardised amounts of each lysed cell type were anal- 
ysed by SDS-PAGE and Western blotting using anti gp 91 phox and anti racl primary 
antibodies and visualised by enhanced chemiluminescence. Results. We demonstrated 
gp 91 phox and RX 1 in human platelets in amounts equal to or greater than that found 
in cultured human HAECs. These componets of NAD(P)H oxidase were found in all sam- 
ples of platelets examined (n=lO). Conclusion. Other workers have demonstrated the 
am- 
ma- 
presence of p22 phox and ~67 phox which along with our observations comprise the 
major components of NAD(P)H oxidase found in human endothelial cells. We suggest 
this makes isolated platelets a suitable model to study changes in endothelial cell super- 
oxide pathway components in response to various interventions. 
1032-121 Binding of FVlla to TF Promotes Smooth Muscle Cell 
Proliferation In Vitro via Activation of the Extracellular 
Regulated Kinases 
Plinio Clnllo, Paolo Golino, Paolo Calabro, Gaetano Cali, Lavinia Forte, Salvatore De 
Rosa, Mario Pacileo, Francesco Scopacasa. Massimo Chiariello, University of Naples, 
Naples, Italy, 2nd University of Naples, Naples, Italy 
&stenosis following PTCA recognizes smooth muscle cell (SMC) prokferation as a key 
event. However, the mechanisms involved are not completely known. Tissue Factor (TF), 
a transmembrane glycoprotem. forms a complex with factor VII (FVII), thus activating the 
coagulation pathway. However, TF may function also es a membrane receptor and we 
have previously shown that binding of activated FVII (FVlla) to TF induces SMC prolifer- 
ation. In the present study we assessed whether this phenomenon is the result of activa- 
tion of the extracellular signal regulated kinase (ERK) pathway. SMCs from rabbit aortas 
were made quiescent by serum deprivation. After 24 hrs, SMCs were stimulated with 
FVlla (100nM) and orocessed for total orotein isolation at baseline (no stimulation). and ,. 
after 1, 2, 5, 15. 20. 30 and 60 min following stimulation. Phosphorylation (activation) of 
ERKs (oERKs) was assessed bv immunoblottina usino anti-oERK antibodv. To better _ _ 
define the role of PERK in SMC proliferation, in additional experiments, SMCs were pre- 
incubated with UO126 (IOpM), an inhibitor of ERK phosphorylation; SMCs were stimu- 
lated with FVlla as above and proliferation (thymidine incorporation) and ERK 
phosphorilation (immunoblotting) evaluated. SMC proliferation appeared to be related to 
ERK activation. as suggested by the observation that UO126 inhibited it. This effect was 
associated with the inhibition (delay) of ERK phosphorilation. Thus, TF/FVlla complex 
leads to SMC proliferation via activation of ERKs. 
KKK - PlroMlbaciblni 
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1032-l 22 The Molecular Mechanisms of Calcium Dependent 
Tissue-Type Plasminogen Activator Release 
James A. Muldownev. Ill, Corrie A. Palmer, Elaine Sanders-Bush, Nancy J. Brown. 
Douglas E. Vaughan, Vanderbilt University Medical Center, Nashville, TN 
Physiologic release of tissue-type plasminogen activator (t-PA) from the endothelium is 
critical for vascular homeostesis. Atherosclerosis and cigarette smoking impair coronary 
release of t-PA. Thrombin-induced t-PA release is a g-protein coupled, calcium-depen- 
dent phenomenon. S is the g-protein primarily responsible for GPCR-dependent csl- 
cium signaling. In this study, we tested the hypothesis that thrombin-induced t-PA 
release is a $, phospholipase-CD (PLCp), and inositol-triphosphate (IP&dependent 
phenomenon. Human microvascular endothelial cells were incubated with2mM sodium 
butyrate for 24 hours. Cells were washed and incubated for 30 minutes in Ml99+0.03% 
albumin and inhibitors in triplicate. Cells were stimulated with 10 U/ml thrombin, agonist, 
or vehicle. Medium was harvested at 0 and 5 minutes, and t-PA antigen was measured 
by ELISA. Cells were pretreated with a decoy peptide identical to the $ c-terminus 
linked to a membrane permeable sequence (MPS-Gd prior to thrombin treatment. A 
peptide containing the 4 sequence was a negative control (MPS-&). Separately, cells 
were stimulated with Pasteurella multocidia toxin (rPMT), a G, agonist. MPS-G, obliter- 
ated thrombin induced t-PA release while MPS-C, did not. Treatment with rPMT, trended 
towards induction of t-PA release at 140 pM. Thrombin-induced t-PA release was inhib- 
ited in a dose-dependent manner by U73122, a PLCQ antagonist (lC,=@M). U73343, 
an inert analog, had no effect. The I& receptor antagonist P-APB also inhibited throm- 
bin-induced t-PA release in a dose-dependent manner (IC&+OpM). Thrombin-induced 
t-PA release in human endothelial cells is $, PLCp. and IPs-dependent. Acquired 
impairment of coronary t-PA release in smokers may involve alterations in one or more 
messengers in this pathway, which may partially explain the increased risk of coronary 
thrombosis in these groups. 
1032-123 Altered Balance of Matrix Metalloproteinase and Tissue 
Inhibitor of Metalloproteinase in Human Atherosclerotic 
Plaque: Evidence From Quantitative Analysis of Gene 
Expression Using Real-Time FIT-PCR Method 
Takeo Hiaashikata, Masakezu Yamagishi. Toshio Higashi, lzumi Nagata, Aiji Sakamoto, 
National Cardiovascular Center Research Institute. Suita, Japan, National 
Cardiovascular Center, Suita. Japan 
Background: Although gene expression survey for atherosclerotic lesion has been 
recently conducted by cDNA array, few data exist regarding quantitative measurement of 
key genes in human atherosclerotic tissue. We developed an efficient procedure that 
makes it possible to quantitate expression levels of various genes in the scarce amount 
of human tissue available. And we tested a hypothesis that altered expression balance of 
matrix metalloproteinases (MMPs) to tissue inhibitors of metalloproteinase (TIMPs) plays 
a pivotal pathogenetical role in human atherosclerosis. 
Methods: Samples of the plaque shoulder region and minimally affected intima were 
obtained from atherosclerotic carotid arteries in 24 patients with carotid endoatterec- 
tomy. Total RNA was extracted from the samples and subjected to cDNA synthesis with 
random primer. Amount of the cDNAs for MMP-I, 2, 3 and 9. and TIMP-I, 2, 3 and 4 in 
each cDNA mixture were determined by real-time RT-PCR method using ABI 7700 
sequence detection system (Appliedbiosystams), and normalized with that of GAPDH 
(glutsraldehyde 3-dehydrogenase) as a reference gene. 
Results: Total RNA (0.49*0.22pg) was successfully extracted from small amount of the 
human samples weighing 11.7*2.64mg, which was adequate for cDNA synthesis. In 
shoulder region, the genes for MMP-1 (1.27+~0.27) and MMP-9 (2.2OkO.55) were signifi- 
cantly augmented than those in minimally affected intima (0.30~0.12 and 0.62+0.24. 
respectively, pcO.01). Also, the expression levels of TIMP-1 and TIMP-3 genes were 
higher in shoulder region (1.22*0.22 vs. 0.61+0.47, and 0.47r0.12 vs. 0.26*0.09, 
respectively). The indices of MMP-ITTIMP-1 and MMP-S/TIMP-1 were 2.6 and 4.5 times 
higher in plaque shoulder region than in minimally affected intima. 
Conclusion: Upregulation of MMPs in plaque shoulder region was disproportional to that 
of TIMPs, suggesting that active degradation of extracellular matrix persists in advanced 
atherosclerotic lesion. We consider that quanbtative measurement of gene expression 
with the present method in human atherosclerotic tissue gives us deep understanding for 
its pathogeneses. 
1032-124 Fibrinolytic Activity and Protein Gene Polymorphisms: 
Association With Coronary Artery Disease 
Raymond L. Benz+. University of Alabama at Birmingham, Birmingham, AL 
Background: Impaired fibrinolytic activity (FA) is associated with atherosclerosis and 
may be determined, in part, by specific fibrinolytic protein (FP) gene polymorphisms 
(PM@, yet interrelationships between these PMs, Fas , and clinical atherosclerosis 
remain unclear. We determined whether associations existed between FP gene PMs, FP 
